drugset / Trial / NCT00000199

Piracetam for Treatment of Cocaine Addiction, Phase II - 4

NCT00000199

Treatment

Summary

The purpose of this study is to follow patients in Phase I of an inpatient study in an eight week open label assessment of piracetam in an outpatient treatment program.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Piracetam Small molecule